Income statement
USD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 191M | 164M | 159M | 132M | 98M |
| Gross Profit | 46M | 42M | 39M | 29M | 25M |
| Operating Income | 6M | 10M | 9M | 129K | 35K |
| EBITDA | 12M | 14M | 15M | 5M | 4M |
| Net Income | -6M | 6M | 7M | -119K | -234K |
| EPS (Diluted) | — | — | — | — | — |
Industrials
Live Price
Offline$6.46
+2.70% today
1Y Change
-21.71%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ultralife Corporation (ULBI) is a Industrials stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $6.46 and down 21.7% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +16.2%, EPS growth of -192.1%, a dividend yield of 0.0%. What stands out right now is revenue +16.2%, EPS -192.1%, free cash flow -51.6% with operating margin 3.3% and ROIC 2.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ULBI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ULBI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ULBI Max Drawdown
-44.69%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ULBI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$98.3M
-25.5% YoY
FY Net Income
-$234.0K
-96.6% YoY
Free Cash Flow
$1.5M
+151.4% YoY
Revenue Growth
+16.2%
EPS Growth
-192.1%
Gross Margin
24.1%
Net Margin
-3.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 191M | 164M | 159M | 132M | 98M |
| Gross Profit | 46M | 42M | 39M | 29M | 25M |
| Operating Income | 6M | 10M | 9M | 129K | 35K |
| EBITDA | 12M | 14M | 15M | 5M | 4M |
| Net Income | -6M | 6M | 7M | -119K | -234K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 9M | 7M | 10M | 6M | 8M |
| Total Assets | 217M | 220M | 178M | 168M | 160M |
| Total Liabilities | 87M | 86M | 53M | 52M | 42M |
| Shareholder Equity | 130M | 134M | 125M | 116M | 118M |
| Total Debt | 50M | 58M | 29M | 24M | 23M |
| Net Debt | 40M | 52M | 19M | 18M | 15M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
4M
+442.4% YoY
Capital Expenditures
3M
-67.6% YoY
Free Cash Flow
2M
+151.4% YoY
Key ratios
Gross Margin
24.1%
Operating Margin
3.3%
Net Margin
-3.1%
ROE
-4.4%
Debt / Equity
0.38x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.